abcam

Spinning plates shouldn’t mean quality is compromised. Deliver results quickly and keep your research flowing with high-quality immunoassays for quicker decision making. Learn more: https://bit.ly/3KZkMgn

There are so many reasons why scientists choose to follow a path into research. But for many, it begins with a moment, often early on in life, that reveals their passion to discover more about the world around them. James E. Trosko, Ph.D., Professor Emeritus at @Michigan State University shares his personal story with us: Dear Abcam, My love for science began in 1967 when Sputnik flew overhead my campus. I was about to drop out of college and has no funds to continue, I won a scholarship that went on to afford me a graduate fellowship to get a Ph.D at Michigan State University. Later in my career, when I transferred to the new Medical School at Michigan State University, the concern of the "ethics" of the new molecular Biology got me a National Cancer Institute Career Development award to work with the late famous cancer biochemist, Dr. Van R. Potter, at the McArdle Lab for Cancer Research. From there, I was given the post of Chief of Research at the Radiation Effects Research Foundation- Hiroshima to study the health effects of the atomic bomb radiation exposure. After coming back to Michigan State University, my lab was the first in the world to isolate normal human organ-specific adult stem cells. We used these stem cells in 3-D to screen for potential new drug and toxicants. There are so many research "detours" during this 50+ year journey. What drove me in my passionate pursuit of answers for various genetic and environmental human diseases was not prizes, money and "fame", but the satisfaction that I uncovered a tiny bit of the mystery behind various diseases. Most satisfying to me now is the legacy of brilliant ex-students, postdocs, colleagues that are currently carrying on the concepts, many techniques developed in my laboratory. I hope this might provide an insight to why I loved science.

Don't miss early bird pricing and the chance to submit an abstract for #LiquidBiopsy24. Find out more here: https://bit.ly/4bYGJaM

One of the biggest challenges of a transition is ensuring that results stay reproducible from lab to lab. Our high-quality recombinant antibodies ensure that no matter where your research takes you, you're always moving forward with confidence in accurate and reproducible results. For antibodies that deliver the same results every time, over time, check out our recombinant range: https://bit.ly/3bFUoaO

Working in blood cancer research? At Abcam, we never stop innovating to fill gaps in the reagent market for novel, emerging targets. We recently launched a new recombinant antibody against GPRC5D – a unique product to support the development of treatments for multiple myeloma. Suitable for IHC and WB applications for human samples, this newly launched reagent is highly specific, supported by detailed characterization data to give you that peace of mind and keep your research moving forward. Find out more, here: https://bit.ly/4c6eeYp #MultipleMyeloma #BloodCancer

When hurdles in your day-to-day are slowing you down, know that your research is under control thanks to high-quality immunoassays that keep you on track – and keep you moving forward. Learn more about staying on track with our immunoassays: https://bit.ly/3KZkMgn

Artificial intelligence (AI) is advancing industries all over the world, and life science is no exception. At Abcam, we embrace AI and use it as a tool to drive science forward. Joining Abcam’s Digital team means you can make a real impact on how AI accelerates the next breakthrough in life sciences. So, if you’re a digital expert with an interest in making a positive impact, we want to hear from you – see our digital technology and data vacancies here: https://bit.ly/3WoWXop

We’re excited to share that we’ve been recognized for our LGBTQ+ inclusivity work by Stonewall – receiving a Silver Award in this year’s Workplace Equality Index 🏳️🌈 A huge thank you to Abcam’s Rainbow Community (our LGBTQ+ employee resource group), for representing our LGBTQ+ community at Abcam and playing a vital role in this journey. Thank you also to our amazing People Experience team, and colleagues across Abcam for their commitment to creating a workplace where everyone can truly be themselves. Read about the news here: https://lnkd.in/gNPH8pUv #PrideInSTEM #WEI #LGBTQ #Stonewall #WorkplaceEqualityIndex

📢 Just published 📢 In their latest paper, our collaborators Dr. Nils Mülling and Graham Heieis use Met-Flow to reveal how inhibition of CD38 can rejuvenate CMV-specific cytotoxic T-cell metabolism and functionality in kidney transplant recipients. Find out more: https://lnkd.in/eww-_yNX The Journal of Clinical Investigation #metflow #immunometabolism #antibody #conjugate #transplant #LUMC

⏰ Deadline approaching ⏰ Submit short talk abstracts and book discounted conference tickets by July 26 for ‘Liquid Biopsy: Beyond-Cell Free Tumor DNA' 🧪🩸 Don't miss out on the chance to expand your network and gain recognition in the field of #liquidbiopsy at our upcoming conference, chaired by Shannon Stott (Massachusetts General Hospital/ Harvard Medical School) and Klaus Pantel (Universitätsklinikum Hamburg Eppendorf) and featuring talks from: 💥Dolores Di Vizio (Cedars-Sinai) 💥Shana Kelley (Northwestern University) 💥Catherine Alix-Panabières (University of Montpellier) 💥Daniel Haber (Massachusetts General Hospital) Submit a short talk abstract to be considered for a place on the main conference program, where we will be exploring all main topics including technical aspects of enrichment, detection and characterization of #circulatingtumorcells, as well as isolation and detection of #extracellularvesicles their clinical applications. This is your opportunity to gain valuable feedback and exchange ideas on how we can advance the field. 📅 Conference date: September 24, 2024 🏢 Location: JB Martin Conference Center, Harvard Medical School, Boston MA, USA 🎫 Tickets: $55 for students and $95 for delegates when booked by July 26 To register for the event and submit an abstract, visit the website: https://lnkd.in/e8Vz2TSx #liquidbiopsy2024 #researchopportunity #callforabstracts #thoughtleadership #networking